14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
May 06, 2024 Sell 7 393 Bradbury Daniel Common Stock
May 06, 2024 Sell 7 967 Bradbury Daniel Common Stock
May 06, 2024 Sell 1 212 Maetzold Derek J Common Stock
May 06, 2024 Sell 1 212 Maetzold Derek J Common Stock
May 06, 2024 Sell 2 368 Maetzold Derek J Common Stock
May 06, 2024 Sell 386 Maetzold Derek J Common Stock
May 06, 2024 Sell 386 Maetzold Derek J Common Stock
Apr 23, 2024 Sell 215 Maetzold Derek J Common Stock
Apr 23, 2024 Sell 215 Maetzold Derek J Common Stock
Apr 23, 2024 Sell 421 Maetzold Derek J Common Stock
Apr 23, 2024 Sell 68 Maetzold Derek J Common Stock
Apr 23, 2024 Sell 69 Maetzold Derek J Common Stock
Apr 12, 2024 Sell 997 Maetzold Derek J Common Stock
Apr 12, 2024 Sell 997 Maetzold Derek J Common Stock
Apr 12, 2024 Sell 1 947 Maetzold Derek J Common Stock
Apr 12, 2024 Sell 318 Maetzold Derek J Common Stock
Apr 12, 2024 Sell 317 Maetzold Derek J Common Stock
Apr 08, 2024 Sell 761 Bradbury Daniel Common Stock
Apr 08, 2024 Sell 820 Bradbury Daniel Common Stock
Apr 08, 2024 Sell 819 Bradbury Daniel Common Stock
Apr 05, 2024 Sell 3 731 Bradbury Daniel Common Stock
Apr 05, 2024 Sell 4 021 Bradbury Daniel Common Stock
Apr 05, 2024 Sell 4 019 Bradbury Daniel Common Stock
Apr 04, 2024 Sell 2 901 Bradbury Daniel Common Stock
Apr 04, 2024 Sell 3 126 Bradbury Daniel Common Stock
Apr 04, 2024 Sell 3 125 Bradbury Daniel Common Stock
Apr 03, 2024 Sell 1 212 Maetzold Derek J Common Stock
Apr 03, 2024 Sell 1 212 Maetzold Derek J Common Stock
Apr 03, 2024 Sell 2 368 Maetzold Derek J Common Stock
Apr 03, 2024 Sell 386 Maetzold Derek J Common Stock
Apr 03, 2024 Sell 386 Maetzold Derek J Common Stock
Mar 26, 2024 Buy 15 988 Cotton Rodney Restricted Stock Units
Mar 26, 2024 Buy 0 Cotton Rodney
Mar 21, 2024 Sell 37 Maetzold Derek J Common Stock
Mar 21, 2024 Sell 37 Maetzold Derek J Common Stock
Mar 21, 2024 Sell 73 Maetzold Derek J Common Stock
Mar 21, 2024 Sell 11 Maetzold Derek J Common Stock
Mar 21, 2024 Sell 12 Maetzold Derek J Common Stock
Mar 20, 2024 Sell 1 175 Maetzold Derek J Common Stock
Mar 20, 2024 Sell 1 175 Maetzold Derek J Common Stock
Mar 20, 2024 Sell 2 295 Maetzold Derek J Common Stock
Mar 20, 2024 Sell 375 Maetzold Derek J Common Stock
Mar 20, 2024 Sell 374 Maetzold Derek J Common Stock
Mar 07, 2024 Sell 1 222 Maetzold Derek J Common Stock
Mar 07, 2024 Sell 1 222 Maetzold Derek J Common Stock
Mar 07, 2024 Sell 2 372 Maetzold Derek J Common Stock
Mar 07, 2024 Sell 388 Maetzold Derek J Common Stock
Mar 07, 2024 Sell 388 Maetzold Derek J Common Stock
Mar 05, 2024 Buy 10 686 Maetzold Derek J Common Stock
Mar 05, 2024 Sell 4 131 Maetzold Derek J Common Stock
Mar 05, 2024 Sell 10 686 Maetzold Derek J Stock option (right to buy)
Mar 04, 2024 Buy 55 243 Juvenal Tobin W Restricted Stock Units
Mar 04, 2024 Buy 55 243 Oelschlager Kristen M Restricted Stock Units
Mar 04, 2024 Buy 48 744 Stokes Frank Restricted Stock Units
Mar 04, 2024 Buy 124 437 Maetzold Derek J Restricted Stock Units
Mar 04, 2024 Sell 5 294 Bradbury Daniel Common Stock
Mar 04, 2024 Sell 2 099 Bradbury Daniel Common Stock
Mar 04, 2024 Sell 5 705 Bradbury Daniel Common Stock
Mar 04, 2024 Sell 5 701 Bradbury Daniel Common Stock
Mar 04, 2024 Sell 2 262 Bradbury Daniel Common Stock
Mar 04, 2024 Sell 2 262 Bradbury Daniel Common Stock
Feb 07, 2024 Sell 658 Bradbury Daniel Common Stock
Feb 07, 2024 Sell 708 Bradbury Daniel Common Stock
Feb 07, 2024 Sell 708 Bradbury Daniel Common Stock
Feb 06, 2024 Sell 3 121 Bradbury Daniel Common Stock
Feb 06, 2024 Sell 3 364 Bradbury Daniel Common Stock
Feb 06, 2024 Sell 3 362 Bradbury Daniel Common Stock
Feb 05, 2024 Sell 2 751 Bradbury Daniel Common Stock
Feb 05, 2024 Sell 863 Bradbury Daniel Common Stock
Feb 05, 2024 Sell 2 964 Bradbury Daniel Common Stock
Feb 05, 2024 Sell 2 963 Bradbury Daniel Common Stock
Feb 05, 2024 Sell 931 Bradbury Daniel Common Stock
Feb 05, 2024 Sell 930 Bradbury Daniel Common Stock
Jan 05, 2024 Sell 1 617 Bradbury Daniel Common Stock
Jan 05, 2024 Sell 1 742 Bradbury Daniel Common Stock
Jan 05, 2024 Sell 1 741 Bradbury Daniel Common Stock
Jan 04, 2024 Sell 5 776 Bradbury Daniel Common Stock
Jan 04, 2024 Sell 6 225 Bradbury Daniel Common Stock
Jan 04, 2024 Sell 6 222 Bradbury Daniel Common Stock
Jan 02, 2024 Buy 3 400 Juvenal Tobin W Common Stock
Jan 02, 2024 Buy 3 301 Juvenal Tobin W Common Stock
Jan 02, 2024 Sell 3 400 Juvenal Tobin W Stock option (right to buy)
Jan 02, 2024 Sell 3 301 Juvenal Tobin W Stock option (right to buy)
Dec 29, 2023 Buy 8 000 Oelschlager Kristen M Common Stock
Dec 29, 2023 Buy 3 418 Oelschlager Kristen M Common Stock
Dec 29, 2023 Buy 1 197 Oelschlager Kristen M Common Stock
Dec 29, 2023 Sell 8 000 Oelschlager Kristen M Stock option (right to buy)
Dec 29, 2023 Sell 3 418 Oelschlager Kristen M Stock option (right to buy)
Dec 29, 2023 Sell 1 197 Oelschlager Kristen M Stock option (right to buy)
Dec 28, 2023 Sell 161 Maetzold Derek J Common Stock
Dec 28, 2023 Sell 161 Maetzold Derek J Common Stock
Dec 28, 2023 Sell 3 954 Maetzold Derek J Common Stock
Dec 28, 2023 Sell 58 Maetzold Derek J Common Stock
Dec 27, 2023 Sell 329 Maetzold Derek J Common Stock
Dec 27, 2023 Sell 329 Maetzold Derek J Common Stock
Dec 27, 2023 Sell 8 076 Maetzold Derek J Common Stock
Dec 27, 2023 Sell 122 Maetzold Derek J Common Stock
Dec 27, 2023 Sell 119 Maetzold Derek J Common Stock
Dec 27, 2023 Sell 119 Maetzold Derek J Common Stock
Dec 27, 2023 Sell 119 Maetzold Derek J Common Stock
INSIDER POWER
28.612
Last 100 transactions
Buy: 329 657 | Sell: 184 180 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 28.612.

In total, the insiders bought 329 657 and sold 184 180 CSTL shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Castle Biosciences, Inc.

Castle Biosciences. Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients w... CSTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT